1.
2.
| Received
28-Sep-2012 |
Accepted
- |
Published
28-Sep-2012 |
Abstract
The study investigates whether corporate disclosure
practices of Indian pharmaceuticals firms approach to
harmonize with IFRS. It suggests that the firms follow
material disclosures if the accounting policies are made
mandatory for the companies while they show diversity
if there is scope for alternative accounting treatments.
Besides the empirical examination, the present study
also puts forward a new methodological approach
(viz., Partial Compatibility Index) in measuring the level
of harmonization. The empirical results show that there
is still space of diversification since the C- index figure
is below its moderate figure (0.60) and the target figure
(1.00) as well
Locked
Subscribed
Open Access
Open Access